Sarasmita Made Ary, Sudarma I Wayan, Jaya Made Krisna Adi, Irham Lalu Muhammad, Susanty Sri
, MClinPharm, is with the Pharmacy Study Program, Faculty of Mathematics and Science, Udayana University, Badung City, Bali Province, Indonesia, and the Department of Clinical Pharmacy, School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan.
, MD, is with the Division of Thoracic and Cardiovascular Surgery, Department of Surgery, Sanglah General Hospital, Bali, Indonesia.
Can J Hosp Pharm. 2024 Jan 10;77(1):e3430. doi: 10.4212/cjhp.3430. eCollection 2024.
Telepharmacy was effectively applied for remote pharmaceutical care during the COVID-19 pandemic.
To determine the implementation of telepharmacy services to support pharmacists in providing pharmaceutical care during the pandemic.
Seven electronic databases were searched from inception to June 2021: PubMed, Ovid MEDLINE, Excerpta Medica database (Embase), Web of Science, Proquest, Scopus, and the Cochrane Database of Systematic Reviews.
The review followed PRISMA guidelines and was registered with the PROSPERO registry of systematic reviews. Reports of original research investigating the implementation of telepharmacy during the COVID-19 pandemic were retrieved. Researchers screened the title and abstract of each article, and then evaluated the full text of eligible articles to identify studies that met the inclusion criteria. Pharmacists' responsibilities and actions were classified in relation to the International Pharmaceutical Federation guideline for managing the COVID-19 pandemic. Extracted data included study characteristics, pharmacists' interventions delivered through a telepharmacy system, and the benefits of telepharmacy implementation.
The database search yielded 1400 articles. After removal of duplicates and articles not meeting the specific inclusion criteria (n = 1381), a total of 19 relevant original research articles were reviewed. According to these studies, telepharmacy was used to perform remote medication review and optimization, assess medication adherence, dispense and deliver medications, educate and counsel patients, promote disease prevention, collaborate with health care providers, and monitor treatment outcomes.
This study highlighted the use of telepharmacy services to support pharmacists' activities during the COVID-19 pandemic. Randomized clinical trials are needed to investigate the long-term efficacy and cost-effectiveness of telepharmacy services.
远程药学在新冠疫情期间有效地应用于远程药学服务。
确定远程药学服务的实施情况,以支持药剂师在疫情期间提供药学服务。
检索了7个电子数据库,从建库至2021年6月:PubMed、Ovid MEDLINE、医学文摘数据库(Embase)、科学引文索引、Proquest、Scopus和Cochrane系统评价数据库。
本综述遵循PRISMA指南,并在PROSPERO系统评价注册库中进行了注册。检索了关于新冠疫情期间远程药学实施情况的原始研究报告。研究人员筛选了每篇文章的标题和摘要,然后评估符合条件文章的全文,以确定符合纳入标准的研究。根据国际药学联合会管理新冠疫情的指南,对药剂师的职责和行动进行了分类。提取的数据包括研究特征、通过远程药学系统提供的药剂师干预措施以及实施远程药学的益处。
数据库检索共得到1400篇文章。在去除重复文章和不符合特定纳入标准的文章(n = 1381)后,共审查了19篇相关的原始研究文章。根据这些研究,远程药学被用于进行远程药物审查和优化、评估药物依从性、调配和递送药物、教育和咨询患者、促进疾病预防、与医疗保健提供者合作以及监测治疗结果。
本研究强调了在新冠疫情期间使用远程药学服务来支持药剂师的活动。需要进行随机临床试验来研究远程药学服务的长期疗效和成本效益。